Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism

by Lars Rejnmark, Peter Schwarz, Mishaela Rubin, Tamara Vokes, Bart Clarke, Intekhab Ahmed, Andrea Palermo, Claudio Marcocci, Uberto Pagotto, Erik Eriksen, Sanchita Mourya, Denka Markova, Susanne Pihl, Michael Beckert, Aimee Shu, Aliya Khan
Published 2021-04-01